Question 1

Does Price T Rowe Associates own CAI stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Price T Rowe Associates holds 1,205,390 shares of CAI (Caris Life Sciences), worth $21.5M.

Question 2

How many shares of CAI does Price T Rowe Associates own?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates holds 1,205,390 shares of CAI (Caris Life Sciences).

Question 3

What is Price T Rowe Associates' CAI position worth?

Accepted Answer

As of its Q2 2026 13F, Price T Rowe Associates' CAI position is worth $21.5M.

Question 4

Is Price T Rowe Associates buying or selling CAI?

Accepted Answer

In Q2 2026, Price T Rowe Associates reduced its CAI position by 3,166,381 shares (-72.4%).

Question 5

When did Price T Rowe Associates first buy CAI?

Accepted Answer

Price T Rowe Associates already held CAI in its Q2 2025 13F, the earliest on record, and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.2M	-72.4%	$21.5M	0.0%	$17.82	0
2026-Q1	Decreased	4.4M	-9.4%	$78.2M	0.0%	$19.38	0
2025-Q4	Decreased	4.8M	-30.3%	$130.3M	0.0%	$27.32	0
2025-Q3	Increased	6.9M	+2.4%	$209.5M	0.0%	$30.00	31
2025-Q2	New	6.8M	-	$180.6M	0.0%	$26.81	42

CAI5 quarters

CAI
5 quarters